Aster DM Healthcare Limited has informed the Exchange about General Updates
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Smallcap 250 and 1.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aster DM Healthcare reported Q1 FY26 (quarter ended June 30, 2025) results. Consolidated revenue from continuing operations grew about 7.6% year-on-year to INR 1,077.87 crores (vs INR 1,001.87 crores), and profit from continuing operations rose to INR 93.56 crores (vs INR 81.00 crores), giving EPS of INR 1.67. Standalone revenue rose to INR 613.04 crores from INR 565.62 crores. The Board approved transfer of assets of Block D (159 beds) of Aster Whitefield Hospital from its wholly owned subsidiary AMHPL to the Company for up to INR 80 crores, to be done on an arm's length basis. A final dividend of INR 1 per share was confirmed with a record date of August 28, 2025, and the 17th AGM is scheduled for September 4, 2025. An exceptional expense of INR 4.39 crores was booked for professional fees on a merger and proposed acquisition. Auditor Deloitte Haskins & Sells issued an unmodified opinion on the results.
Steady mid-single-digit revenue growth and improving profit from continuing operations post the GCC business separation are mildly positive. The intra-group asset transfer is a structural realignment, not new capital allocation, and the small dividend is largely token, so near-term stock reaction is likely neutral.